ICS 2024 Scientific Podium Short Oral Session S17 - Refractory Overactive Bladder: Neuromodulation and Botulinum

ICS Members Only

Become an ICS Member today to watch

Join ICS Sign in

{{CC.VideoPaywalButtonText}} Sign in Sign in

Restricted Video

Sign in to watch

You do not have permission to view this video

ICS members can access all the meeting webcasts

Sign in Join Now

ICS Members Only Restricted Video

Speakers
	Scientific Podium Short Oral Session S17
	Thursday 24th October 2024
	15:00 - 16:30
	Hall N106 Capacity: 200
	Lunch provided
	Live Translation Available Find out more
	Recorded for Gold Pass attendees Find out more
C Charalampos Konstantinidis ICS Chair B Bárbara Yolanda Padilla Fernández ICS Chair
Professional interest
Urology

15:00

#167 Two-year Follow-up of Revi™ Therapy, Implantable Tibial Neuromodulation (iTNM) for the Treatment of Urinary Urge Incontinence: The OASIS Study
Best in Category Prize: Overactive Bladder

Presenter: Suzaeete Sutherland, United States

Sutherland S¹, Heesakkers J², Tooz-Hobson P³, Amundsen C⁴, McCrery R⁵, Kean E⁶, De Wachter S⁷, Benson K⁸, Martens F⁹, Ferrrante K¹⁰, Padron O¹¹, Giusto L¹², Pezzella A¹³, Digesu A¹⁴, Dmochowski R¹⁵
1. University of Washington, 2. Maastricht, 3. University of Birmingham, 4. Duke University, 5. Adult and Ped Urology, Omaha, NE, 6. Adult and Red Urology, Omaha, NE, 7. Antwerp University, 8. Sanford Health Care, SD, USA, 9. Radboud Medical Center, 10. Kaiser Permanente, San Diego, CA, 11. Urology Partners, Tampa, FL, USA, 12. Chesapeake Urology, Baltimore, MD, USA, 13. Southern Urogynecology,, 14. Imperial College, 15. Vanderbilt Medical Center
Incontinence, Surgery, Neuromodulation, Female, New Devices

15:07

#168 Dorsal Genital Nerve stimulation in patients with overactive bladder syndrome. A feasibility study with the novel UCon neurostimulator

Presenter: Meryam El Issaoui, Denmark

El Issaoui M¹, Glavind-Kristensen M², Graugaard-Jensen C³, Qvist N⁴, Rijkhoff N⁴, Schmidt Grau L⁵, Kjeldgaard Jakobsen J⁵, Andersen K⁶, Kobberø H⁶, Christensen P⁵, Klarskov N¹
1. Department of Obstetrics and Gynecology, Herlev and Gentofte University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, 2. Department of Obstetrics and Gynecology, Aarhus University Hospital, 3. Department of Urology, Aarhus University Hospital, 4. Research Unit for Surgery, Odense University Hospital, University of Southern Denmark, 5. Pelvic Floor Unit, Department of Surgery, Aarhus University Hospital, 6. Department of Urology, Odense University Hospital, Research Unit of Urology, Department of Clinical Research, University of Southern Denmark
Neuromodulation, New Devices, Urgency Urinary Incontinence, Urgency/Frequency, Overactive Bladder

15:15

#169 A closer look into overactive bladder syndrome: exploring the use of NESA microcurrents neuromodulation.

Presenter: María González Bueso, Spain

Ruiz López K¹, Medina Ramírez R², González Bueso M³, Conde Santos G⁴, Martín Martinez A⁵, Carballo Rastrilla S⁵, Quintana Montesdeoca M², Hernández Pérez A²
1. Centro de fisioterapia pelviperineal Ketty Ruiz, 2. Universidad de Las Palmas de Gran Canaria, 3. Clínica de fisioterapia María González, 4. Hospital Quirónsalud, 5. Hospital Universitario Insular-Materno infantil
Overactive Bladder, Neuromodulation, Urgency Urinary Incontinence, Quality of Life (QoL)

15:30

#171 Comparison of the Transcutaneous Posterior Tibial Nerve Stimulation and Solifenacin Treatments’ Effects in Women with Overactive Bladder

Presenter: Ahmet Ozgur Yeniel, Turkey

Memmedova S¹, Acar A², Ozceltik G¹, Itil İ¹, Yeniel A¹
1. Department of Obstetrics and Gynecology, Faculty of Medicine, Ege University, Izmir, Turkey, 2. Institute of Health Sciences, Izmir Katip Celebi University, Izmir, Turkey
Overactive Bladder, Urgency Urinary Incontinence, Conservative Treatment, Neuromodulation

15:37

#172 Selective Bladder Denervation with Radiofrequency Ablation vs Intramuscular Botulinum Toxin Injection in Patients with Refractory Overactive Bladder: A Preliminary Report of Prospective Randomized Comparative Study

Presenter: Salih Zeki Sönmez, Turkey

Sönmez S¹, Dinçer M¹
1. University of Health Sciences Istanbul Bagcilar Hospital, Turkey, Urology Clinic ‐ İstanbul, Turkey
Female, Overactive Bladder, Prospective Study, Clinical Trial, New Devices

15:45

#173 Predictive factors for clean intermittent catheterization after intravesical onabotulinumtoxinA injections in women with overactive bladder syndrome: A Danish retrospective cohort study

Presenter: Meryam El Issaoui, Denmark

El Issaoui M¹, Elissaoui S², Elmelund M², Klarskov N¹
1. Department of Obstetrics and Gynecology, Herlev and Gentofte University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, 2. Department of Obstetrics and Gynecology, Herlev and Gentofte University Hospital
Female, Overactive Bladder, Retrospective Study, Voiding Dysfunction

15:52

#174 A dynamic nomogram predicting success of intradetrusoral injections of botulinum toxin in idiopathic refractory overactive bladder

Presenter: Sarah Thiry, Belgium

Thiry S¹, Englebert A², Everaert K³, Bou Kheir G³, Hervé F³
1. UCL Mont Godinne, 2. Information and Communication Technologies, Electronics and Applied Mathematics (ICTEAM),UCLouvain, Belgium ³Orthopaedic Surgery and Traumatology Department, Cliniques Universitaires Saint-Luc UCL, Neuro Musculo Skeletal Lab (NMSK), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium, 3. Ghent University Hospital
Detrusor Overactivity, New Instrumentation, Outcomes Research Methods, Urgency/Frequency

16:00

#175 Long term effectiveness and treatment adherence of botulinum toxin injections for neurogenic detrusor overactivity

Presenter: Julia Neuenschwander, Switzerland

Neuenschwander J¹, Widmer A¹, Krebs J¹, Pannek J¹, Wöllner J¹
1. Swiss Paraplegic Centre
Incontinence, Spinal Cord Injury, Detrusor Overactivity, Retrospective Study

16:07

#176 Prospective, observational study of the prevalence and risk factors for UTI following Onabotulinum Toxin A injections for Idiopathic OAB

Presenter: Nicholas Raison, United Kingdom

Raison N¹, Malde S², Faure-Walker N³, Robinson D³, Rantell A³, Taylor C³, Sahai A²
1. King's College London, 2. Guys & St Thomas' NHS Trust, 3. King's College Hospital
Overactive Bladder, Urgency Urinary Incontinence, Detrusor Overactivity

16:22

#178 Botuline Toxine A in Overactive Bladder Therapy: Variation in Practice Amongst 258 Survey Responders in Belgium and the Netherlands

Presenter: A.A. Pronk, Netherlands

Pronk A¹, Schlatmann F², Hervé F³, Van der Aa F⁴, van Balken M¹
1. Rijnstate, 2. Spaarne Gasthuis, 3. UZ Gent, 4. UZ Leuven
Detrusor Overactivity, Overactive Bladder, Surgery, Urgency Urinary Incontinence, Urgency/Frequency

Content Visitors (staff only)

Refractory Overactive Bladder: Neuromodulation and Botulinum

ICS Members Only

ICS Members Only

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

Restricted Video

Restricted Video

Session Schedule

Refractory Overactive Bladder: Neuromodulation and Botulinum

ICS Members Only

ICS Members Only

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

Restricted Video

Restricted Video

ICS Members Only Restricted Video

Session Schedule

Comments

Chat